<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">8507085</journal-id>
<journal-id journal-id-type="pubmed-jr-id">7839</journal-id>
<journal-id journal-id-type="nlm-ta">Trends Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">Trends Genet.</journal-id>
<journal-title-group>
<journal-title>Trends in genetics : TIG</journal-title>
</journal-title-group>
<issn pub-type="ppub">0168-9525</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31182245</article-id>
<article-id pub-id-type="pmc">6625889</article-id>
<article-id pub-id-type="doi">10.1016/j.tig.2019.05.004</article-id>
<article-id pub-id-type="manuscript">NIHMS1530098</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Poly(ADP-ribosylation) in age-related neurological disease</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>McGurk</surname>
<given-names>Leeanne</given-names>
</name>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rifai</surname>
<given-names>Olivia M.</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bonini</surname>
<given-names>Nancy M.</given-names>
</name>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
<aff id="A1">Department of Biology, University of Pennsylvania, Philadelphia, PA 19104, USA</aff>
</contrib-group>
<author-notes>
<corresp id="CR1"><label>*</label>corresponding authors.</corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>23</day>
<month>5</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>07</day>
<month>6</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="ppub">
<month>8</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>8</month>
<year>2020</year>
</pub-date>
<volume>35</volume>
<issue>8</issue>
<fpage>601</fpage>
<lpage>613</lpage>
<!--elocation-id from pubmed: 10.1016/j.tig.2019.05.004-->
<abstract id="ABS1">
<p id="P1">A central and causative feature of age-related neurodegenerative disease is the deposition of misfolded proteins in the brain. To devise novel approaches to treatment, regulatory pathways that modulate these aggregation-prone proteins must be defined. One such pathway is the post-translational modification poly(ADP-ribose), which promotes protein localization in a number of cellular contexts. Mounting evidence implicates poly(ADP-ribose) in seeding the abnormal localization and accumulation of proteins causative of neurodegenerative disease. Inhibitors of poly(ADP-ribose) activity have been developed as cancer therapeutics, raising the possibility that they could be applied to treatment of neurodegenerative disease. Here, we focus on pathways regulated by poly(ADP-ribose) in neurodegenerative disease, with emphasis on amyotrophic laterals sclerosis and frontotemporal degeneration.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>